North Star Asset Management Inc Ginkgo Bioworks Holdings, Inc. Transaction History

North Star Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.28 - $1.16 $40,068 - $165,996	143,100 Added 162.61%	231,100 $76,000
Q1 2024 May 08, 2024	BUY	$1.06 - $1.67 $27,401 - $43,169	25,850 Added 41.59%	88,000 $102,000
Q4 2023 Feb 01, 2024	BUY	$1.26 - $1.79 $10,080 - $14,320	8,000 Added 14.77%	62,150 $105,000
Q3 2023 Oct 26, 2023	BUY	$1.61 - $2.54 $57,396 - $90,551	35,650 Added 192.7%	54,150 $98,000
Q2 2023 Aug 09, 2023	SELL	$1.14 - $1.95 $1,823 - $3,120	-1,600 Reduced 7.96%	18,500 $34,000
Q1 2023 May 10, 2023	SELL	$1.2 - $2.19 $19,800 - $36,135	-16,500 Reduced 45.08%	20,100 $26,000
Q4 2022 Mar 06, 2023	BUY	$1.63 - $3.52 $17,930 - $38,720	11,000 Added 42.97%	36,600 $61,000
Q3 2022 Nov 08, 2022	SELL	$0.73 - $3.74 $1,204 - $6,171	-1,650 Reduced 6.06%	25,600 $80,000
Q2 2022 Jul 28, 2022	BUY	$2.2 - $4.2 $59,950 - $114,450	27,250 New	27,250 $65,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on North Star Asset Management Inc with notifications on news.